Published in Neurol Sci on November 04, 2015
Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts. CNS Drugs (2016) 0.75
Pain, cognition and quality of life associate with structural measures of brain volume loss in multiple sclerosis. NeuroRehabilitation (2016) 0.75
Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study. PLoS One (2017) 0.75
The Effect of 20 Minutes Scuba Diving on Cognitive Function of Professional Scuba Divers. Asian J Sports Med (2016) 0.75
Effect of exercise therapy on quality of life of patients with multiple sclerosis in Iran: a systematic review and meta-analysis. Neurol Sci (2017) 0.75
The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis. Front Neurol (2017) 0.75
Advances in clinical neurology through the journal "Neurological Sciences" (2015-2016). Neurol Sci (2017) 0.75
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology (1983) 40.64
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med (2011) 4.02
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis. Ann Neurol (2014) 2.51
Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology (1999) 2.40
Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain (2002) 2.30
Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol (2009) 2.20
Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology (2007) 2.10
Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol (2007) 2.07
Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain (2002) 2.01
Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol (2004) 1.82
Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines. AJNR Am J Neuroradiol (2006) 1.78
Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch Neurol (2006) 1.76
Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study. Neurology (2013) 1.72
Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain (1996) 1.69
Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol (2001) 1.64
Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler (2011) 1.51
Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol (2011) 1.51
Natural history of multiple sclerosis. Ann Neurol (1994) 1.48
Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology (2004) 1.36
MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability. Neurology (2006) 1.29
Revisiting brain atrophy and its relationship to disability in multiple sclerosis. PLoS One (2012) 1.26
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. Arch Neurol (2007) 1.22
Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy. J Neurol Neurosurg Psychiatry (2008) 1.19
Primary progressive multiple sclerosis: a 5-year clinical and MR study. Brain (2003) 1.17
Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients. Mult Scler (2000) 1.07
Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis. Arch Neurol (2006) 1.05
Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. Brain (2005) 1.02
Brain reserve and cognitive reserve in multiple sclerosis: what you've got and how you use it. Neurology (2013) 1.02
Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis. Mult Scler (2007) 0.99
Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis. Mult Scler (2008) 0.97
Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis. Mult Scler (2005) 0.96
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes. Neurology (2012) 0.93
Association of fatigue and brain atrophy in multiple sclerosis. J Neurol Sci (2004) 0.92
Early cognitive impairment in multiple sclerosis predicts disability outcome several years later. Mult Scler (2010) 0.92
Evolving expectations around early management of multiple sclerosis. Ther Adv Neurol Disord (2010) 0.91
Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis. Neuroimage (2004) 0.90
Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging. Brain (1998) 0.90
Multiple sclerosis is primarily a neurodegenerative disease. J Neural Transm (Vienna) (2013) 0.88
Validity of a computerized version of the symbol digit modalities test in multiple sclerosis. J Neurol (2010) 0.88
Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study. PLoS One (2013) 0.88
Regional brain atrophy development is related to specific aspects of clinical dysfunction in multiple sclerosis. Neuroimage (2007) 0.87
Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves. J Neurol Neurosurg Psychiatry (2005) 0.86
A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis. J Neurol (2010) 0.86
Memory performance in multiple sclerosis patients correlates with central brain atrophy. Mult Scler (2006) 0.83
Correlations between MRI and Information Processing Speed in MS: A Meta-Analysis. Mult Scler Int (2014) 0.83
Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis. J Neurol (2009) 0.80
Frontal parenchymal atrophy measures in multiple sclerosis. Mult Scler (2004) 0.76
Characteristics of neurological and cognitive status in patients with multiple sclerosis in relation to the location and volumes of demyelination foci and the severity of brain atrophy. Neurosci Behav Physiol (2009) 0.76